[
  {
    "ts": null,
    "headline": "Incyte Gets FDA Nod for the Expanded Use of Monjuvi in Lymphoma",
    "summary": "The FDA approves INCY's Monjuvi in combination with rituximab and lenalidomide for relapsed/refractory follicular lymphoma, its second approved indication.",
    "url": "https://finnhub.io/api/news?id=cc59a33f76f48de1bdb6b1a5cd96bf79fbf3b5d0c628ff454b2a6225ddc69ef2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750345860,
      "headline": "Incyte Gets FDA Nod for the Expanded Use of Monjuvi in Lymphoma",
      "id": 135397404,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "INCY",
      "source": "Yahoo",
      "summary": "The FDA approves INCY's Monjuvi in combination with rituximab and lenalidomide for relapsed/refractory follicular lymphoma, its second approved indication.",
      "url": "https://finnhub.io/api/news?id=cc59a33f76f48de1bdb6b1a5cd96bf79fbf3b5d0c628ff454b2a6225ddc69ef2"
    }
  }
]